Viva BioInnovator logo

Viva BioInnovator

Asia, Shanghai, China, Shanghai

Description

Viva BioInnovator is the specialized investment and incubation arm of Viva Biotech.

Investor Profile

Viva BioInnovator has made 26 investments, with 0 in the past 12 months and 12% as lead.

Stage Focus

  • Seed (54%)
  • Series A (19%)
  • Series B (15%)
  • Series Unknown (8%)
  • Series C (4%)

Country Focus

  • United States (69%)
  • Switzerland (12%)
  • Canada (12%)
  • Denmark (4%)
  • France (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Biopharma
  • Genetics
  • Life Science
  • Human Resources
  • Artificial Intelligence (Ai)
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Viva BioInnovator frequently co-invest with?

Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 3
Apollo Health Ventures
Europe, Hamburg, Germany, Hamburg
Co-Investments: 3
Lumira Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 6
4See Ventures
Europe, Geneve, Switzerland, Secheron
Co-Investments: 3
BB
Europe, Zug, Switzerland, Zug
Co-Investments: 3
Broadview Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 5
Echo Investment Capital
North America, Oklahoma, United States, Oklahoma City
Co-Investments: 2
CTI Life Sciences Fund
North America, Quebec, Canada, Montréal
Co-Investments: 2
adMare Bio Innovations
North America, British Columbia, Canada, Vancouver
Co-Investments: 2
Schroder Adveq
Europe, Zurich, Switzerland, Zürich
Co-Investments: 3

Which angels does Viva BioInnovator often collaborate with?

JM
North America, United States
Shared Deals: 1
Stephen Thompson
Oceania, Victoria, Australia, Melbourne
Shared Deals: 1
WW
North America, California, United States, Santa Monica
Shared Deals: 1
PS
North America, California, United States, San Mateo
Shared Deals: 1

What are some of recent deals done by Viva BioInnovator?

Deka Biosciences

Germantown, Maryland, United States

Early stage biotechnology company

BiotechnologyHealth Care
Series BSep 28, 2023
Amount Raised: $20,000,000
Reglagene

Tucson, Arizona, United States

Reglagene mainly engages in transforming tubulin therapy for brain diseases.

BiotechnologyLife ScienceMedical
Series UnknownAug 1, 2023
Domain Therapeutics

Illkirch, Alsace, France

Domain Therapeutics develops small molecules targeting G-coupled protein receptors.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series AMay 10, 2022
Amount Raised: $41,063,697
ArrePath

Princeton, New Jersey, United States

ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.

BiotechnologyHealth CareMedical
SeedMar 3, 2022
Amount Raised: $20,000,000
HAYA Therapeutics

Lausanne, Vaud, Switzerland

HAYA Therapeutics is a biopharmaceutical company that specializes in treating heart failure diseases.

BiopharmaBiotechnologyHealth CareMedical
SeedFeb 9, 2022
Amount Raised: $5,000,000
Amberstone Biosciences

Laguna Hills, California, United States

Amberstone Biosciences discovers novel immunotherapies through innovative technologies and creative partnerships.

BiotechnologyHealth CareMedical
Series AJan 3, 2022
Amount Raised: $12,000,000
Vincere Biosciences

Cambridge, Massachusetts, United States

Vincere Biosciences is a JLABS incubator company whose mission is to develop drugs to halt the progression of Parkinson's disease (PD).

Biotechnology
SeedJan 1, 2022
Deka Biosciences

Germantown, Maryland, United States

Early stage biotechnology company

BiotechnologyHealth Care
Series AOct 29, 2021
Amount Raised: $20,000,000
IpiNovyx Bio

West Nyack, New York, United States

IpiNovyx Bio is a biopharmaceutical company developing immunoproteasome-modulating therapeutics to treat autoimmune diseases.

BiopharmaBiotechnologyHealth CareMedical
SeedOct 5, 2021
Amount Raised: $10,000,000
Karma Biotechnologies

Torrance, California, United States

Karma Biotechnologies is solving autoimmunity, allergies, and food sensitivities with our Xavine™ precision immunotherapy platform.

Biotechnology
SeedSep 1, 2021
Amount Raised: $2,780,000